J.&.J. Says It Is Cleared to Offer New Products
110146
Johnson & Johnson said Thursday that its Cordis unit has resolved its issues with the F.D.A., clearing the way for the introduction of new cardiovascular devices.
581625
New rules about sunscreen could mean a new market leader.
761615
Credit Suisse First Boston said it was &quot;still cautious&quot; regarding Johnson &amp; Johnson (nyse: JNJ - news - people ) after the company reported quarterly results above Wall Street estimates.
753065
J&J's blues may indicate trouble ahead for competitors.
710794
Auto parts supplier Johnson Controls  Inc. JCI.N said on Friday that it expects higher sales and  earnings in fiscal 2005, driven by strength in both its  automotive group and controls businesses.
381940
The company's shares have recovered from legal settlement sticker shock.
285856
The longtime partners are expected to announce a new deal that looks likely to cover business services.
157558
New acquisitions and products should increase sales.
246083
Johnson &amp; Johnson (JNJ.N: Quote, Profile, Research) will buy Guidant Corp. (GDT.N: Quote, Profile, Research) for $23.9 billion in cash and stock, giving the health-care products
431415
J Sainsbury PLC has acquired convenience store chain Jacksons Stores Ltd and its wholly owned subsidiary Jacksons Stores 2002 Ltd, the United Kingdom's leading independent, regional c-store chain, with 114 ...
479451
As part of its update of its EnterpriseOne suite, PeopleSoft (Nasdaq: PSFT) has launched two new applications targeted toward the established customer base of what used to be J.D. Edwards (Nasdaq: JDEC) -- manufacturing enterprises.
356822
The Food and Drug Administration yesterday permitted a unit of Johnson &amp; Johnson to market an artificial spinal disk in the United States as a new form of treatment for people with severe lower back pain.
416523
Johnson &amp; Johnson (JNJ:NYSE - news - research) said Tuesday that the Food and Drug Administration had approved its Charite artificial disc, the first such device for treating lower back pain.
85267
Johnson &amp; Johnson agreed to acquire Guidant Corp. for $25.4 billion, adding electrical devices for treating heart disease to a lineup of thousands of health products including Band-Aids and cardiac stents.
282706
The retailer posts impressive comps growth and has updated its guidance.
393015
Company says changes were made due to information that came to light during the trial and to address concerns raised by the judge.
237620
A Johnson &amp; Johnson drug received expanded federal approval Friday to treat aggression and other symptoms of autism in children.